Literature DB >> 35003890

Implementation of level-2 biosafety for a macromolecular crystallography beamline at SSRF.

Huating Kong1, Minjun Li1, Qin Xu1,2, Huan Zhou1, Feng Yu1, Qisheng Wang1,3.   

Abstract

Macromolecular crystallography is commonly used to determine the structure of biological macromolecules. Currently the beamlines at synchrotron radiation facilities play an important role in macromolecular crystallography, and have produced an enormous number of molecular structures to help solve scientific questions and support applications. Structure information makes significant contributions to the virus-related research as well. However, it is mandatory to be protected the operators under a compatible biosafety infrastructure when a pathological agent is set up in a beamline. Here a level-2 biosafety protection for a macromolecular crystallography beamline at Shanghai Synchrotron Radiation Facility (SSRF) is introduced. To fulfill the biosafety in a radioactive environment, a dedicated design is implemented. Since the beamline will be opened to the external users from nationwide research units, the management process and experimental method are also drawn up. AJNMMI
Copyright © 2021.

Entities:  

Keywords:  Macromolecular crystallography; beamline; biosafety; crystal structure; in-situ

Year:  2021        PMID: 35003890      PMCID: PMC8727877     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  20 in total

1.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 2.  A brief history of macromolecular crystallography, illustrated by a family tree and its Nobel fruits.

Authors:  Mariusz Jaskolski; Zbigniew Dauter; Alexander Wlodawer
Journal:  FEBS J       Date:  2014-04-17       Impact factor: 5.542

3.  Human neutralizing antibodies elicited by SARS-CoV-2 infection.

Authors:  Bin Ju; Qi Zhang; Jiwan Ge; Ruoke Wang; Jing Sun; Xiangyang Ge; Jiazhen Yu; Sisi Shan; Bing Zhou; Shuo Song; Xian Tang; Jinfang Yu; Jun Lan; Jing Yuan; Haiyan Wang; Juanjuan Zhao; Shuye Zhang; Youchun Wang; Xuanling Shi; Lei Liu; Jincun Zhao; Xinquan Wang; Zheng Zhang; Linqi Zhang
Journal:  Nature       Date:  2020-05-26       Impact factor: 49.962

4.  A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.

Authors:  Rui Shi; Chao Shan; Xiaomin Duan; Zhihai Chen; Peipei Liu; Jinwen Song; Tao Song; Xiaoshan Bi; Chao Han; Lianao Wu; Ge Gao; Xue Hu; Yanan Zhang; Zhou Tong; Weijin Huang; William Jun Liu; Guizhen Wu; Bo Zhang; Lan Wang; Jianxun Qi; Hui Feng; Fu-Sheng Wang; Qihui Wang; George Fu Gao; Zhiming Yuan; Jinghua Yan
Journal:  Nature       Date:  2020-05-26       Impact factor: 49.962

5.  Structural basis for sequence-specific recognition of DNA by TAL effectors.

Authors:  Dong Deng; Chuangye Yan; Xiaojing Pan; Magdy Mahfouz; Jiawei Wang; Jian-Kang Zhu; Yigong Shi; Nieng Yan
Journal:  Science       Date:  2012-01-05       Impact factor: 47.728

6.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

7.  Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.

Authors:  Wenhao Dai; Bing Zhang; Xia-Ming Jiang; Haixia Su; Jian Li; Yao Zhao; Xiong Xie; Zhenming Jin; Jingjing Peng; Fengjiang Liu; Chunpu Li; You Li; Fang Bai; Haofeng Wang; Xi Cheng; Xiaobo Cen; Shulei Hu; Xiuna Yang; Jiang Wang; Xiang Liu; Gengfu Xiao; Hualiang Jiang; Zihe Rao; Lei-Ke Zhang; Yechun Xu; Haitao Yang; Hong Liu
Journal:  Science       Date:  2020-04-22       Impact factor: 47.728

8.  Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

Authors:  Guangwen Lu; Yawei Hu; Qihui Wang; Jianxun Qi; Feng Gao; Yan Li; Yanfang Zhang; Wei Zhang; Yuan Yuan; Jinku Bao; Buchang Zhang; Yi Shi; Jinghua Yan; George F Gao
Journal:  Nature       Date:  2013-07-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.